Abstract
Bangladesh registered 1573828 confirmed cases of COVID-19 and the death toll crossed the grim milestone of 27946 across the country as of 9th December, 2021. Despite the enforcement of stringent COVID-19 measures, including nationwide lockdowns, travel bans, tighter curbs on nonessential activities, and social distancing, the country witnessed an accelerated diffusion of coronavirus cases during the national events and festivals in 2020. The present study aims to examine the association between the national events / festivals and the transmission dynamics of COVID-19 by looking at the instantaneous reproduction number, Rt, of the 64 districts in Bangladesh. We further illustrate the COVID-19 diffusion explicitly in Dhaka Division at the first phase of the pandemic. The comprehensive analysis shows an escalation of Rt value in Dhaka and in all industrialized cities during the major events such as, Garments reopening and religious holidays in Bangladesh. Based on the analysis, a set of array measurements has been also suggested to evade the future pandemic risks while running the national festival activities.
Highlights
Bangladesh confirmed 1573828 coronavirus cases and 27946 deaths due to the current COVID-19 outbreak.
Country observed significant COVID-19 diffusion in its business hubs during national holidays.
Dhaka, the capital of Bangladesh, is the epicenter of the ongoing pandemic.
Calculated Rt value illustrates its escalation in Dhaka and its neighboring cities at the time of national events.
Bangladesh Government needs to consider interdisciplinary approaches and contextual policies to contain the future pandemic during any national events.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding available for this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NA
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
All data (case number) were collected from the IEDCR, Bangladesh website.
